CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 195 enrolled
Drug / intervention
LoFric Primo (POBE) single-use urinary catheter +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00753298
NCT00753298N/ACompleted

A Multi-centre, Double-blind, Randomized, Parallel Groups Study Comparing PVC and Polyolefin-based Elastomer (POBE) as Catheter Materials, Outcomes Will be Measured by Subject Perception.

Wellspect HealthCare·interventional·Posted Sep 16, 2008·Updated Nov 11, 2021

In Brief

A clinical study evaluating LoFric Primo (POBE) single-use urinary catheter and LoFric Primo (PVC) single-use urinary catheter for Urinary Catheterization. Completed, enrolled 195 participants across 13 sites in 6 countries.

Detailed Summary

The study is designed as a randomized, double-blind, parallel-group, multi centre study comparing perception and tolerability of investigational product and comparator. In the randomized part of the study the subjects will be given either LoFric Primo (POBE) or the comparator LoFric Primo (PVC) for use over 4 weeks. The hypothesis is that subject perception and satisfaction of POBE is equal to or better than for PVC.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Germany, Italy, Netherlands, Sweden, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2008
Enrollment StartJan 1, 2007
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 17.8 years ago

Interventions

LoFric Primo (POBE) single-use urinary catheterdevice

LoFric Primo (POBE) single-use urinary catheter

LoFric Primo (PVC) single-use urinary catheterdevice

LoFric Primo (PVC) single-use urinary catheter